New diagnostic tests on the brink for Spinal Muscle Atrophy
In a groundbreaking effort to combat the devastating effects of Spinal Muscular Atrophy (SMA), Dr. Jean Giacomotto from the Griffith...
Search all articles within the Griffith Institute for Drug Discovery topic
In a groundbreaking effort to combat the devastating effects of Spinal Muscular Atrophy (SMA), Dr. Jean Giacomotto from the Griffith...
Native Charge Detection Mass Spectrometry will enable cross-collaboration research to develop life-changing therapies, vaccines and diagnostics.
Researchers have made a breakthrough discovery into how cancer cells manipulate the immune system.
A new report has offered fresh insights into the burden Parkinson's places on those affected.
Advanced bionic limb development, malaria drug mechanisms, skin immune response to mosquito-borne infections among new Ideas Grants.
Nine new Griffith-led ARC Discovery Projects awarded $3,622,738.
Traditional Knowledge and western science reveal novel, natural remedy for treatment of severe pain.
A state-of-the-art livecyte microscope at the Griffith Institute for Drug Discovery is leading the Spinal Injury Project team toward human clinical trials.
Cutting-edge research and transformative applications achieves real-world impact.
A national team of experts will advance an innovative biopolymer particle-based platform technology to develop vaccine candidates to protect against biowarfare threats.